Column GROUP L P, 10% Owner at NGM BIOPHARMACEUTICALS INC (NGM), bought 487,118 shares at $12.53 ($6.0M) on 2020-03-31, disclosed to the SEC on 2020-04-02.
Open-market purchase of $6.0M NGM by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.53 | 118,067 | $1.5M | 24.5% |
| 2 | $12.53 | 118,067 | $1.5M | 24.5% |
| 3 | $12.26 | 118,067 | $1.4M | 24.0% |
| 4 | $12.26 | 118,067 | $1.4M | 24.0% |
| 5 | $12.40 | 14,850 | $184K | 3.0% |
| Total | $12.40 avg | 487,118 |
| $6.0M |
| 100% |
| Filing → |
| NGM | BUY | 2023-01-12 | $2.0M | — | Filing → |
| NGM | BUY | 2022-11-07 | $1.4M | — | Filing → |
| NGM | BUY | 2022-10-31 | $747K | — | Filing → |